Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas E Kimber

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Internal Medicine Journal|February 2, 2017
Long-term adherence to apomorphine infusion in patients with Parkinson disease: a 10-year observational studyThomas E Kimber, Jing Fang, Lynda J Huddy, et al.
The Medical Journal of Australia|June 17, 2019
Updates and advances in the treatment of Parkinson diseaseMichael W Hayes, Victor Sc Fung, Thomas E Kimber, et al.
Neurosurgery|February 11, 2011
High-frequency pallidal stimulation for camptocormia in Parkinson disease: case reportNova B Thani, Arul Bala, Thomas E Kimber, et al.
Journal of the Peripheral Nervous System : JPNS|April 8, 2003
Pathological findings in a patient with ventilatory failure and chronic inflammatory demyelinating polyneuropathyThomas E Kimber, Richard W Orrell, Rosalind H M King, et al.
The Medical Journal of Australia|February 4, 2010
Current concepts in the management of Parkinson diseaseMichael W Hayes, Victor S Fung, Thomas E Kimber, et al.
World Journal of Gastroenterology|May 31, 2016
Gastric emptying, postprandial blood pressure, glycaemia and splanchnic flow in Parkinson's diseaseLaurence G Trahair, Thomas E Kimber, Katerina Flabouris, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 30, 2008
The distinctive movement disorder of ovarian teratoma-associated encephalitisTimothy J Kleinig, Philip D Thompson, Walid Matar, et al.
NPJ Parkinson'S Disease|July 9, 2025
Faecal microbiota transplant in Parkinson's disease: pilot study to establish safety & tolerabilityMichele De Sciscio, Robert V Bryant, Sarah Haylock-Jacobs, et al.
The Lancet. Neurology|November 19, 2022
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trialMichael J Soileau, Jason Aldred, Kumar Budur, et al.
The Lancet. Neurology|February 26, 2008
Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trialStephen M Davis, Geoffrey A Donnan, Mark W Parsons, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Internal Medicine Journal|February 2, 2017
Long-term adherence to apomorphine infusion in patients with Parkinson disease: a 10-year observational studyThomas E Kimber, Jing Fang, Lynda J Huddy, et al.
The Medical Journal of Australia|June 17, 2019
Updates and advances in the treatment of Parkinson diseaseMichael W Hayes, Victor Sc Fung, Thomas E Kimber, et al.
Neurosurgery|February 11, 2011
High-frequency pallidal stimulation for camptocormia in Parkinson disease: case reportNova B Thani, Arul Bala, Thomas E Kimber, et al.
Journal of the Peripheral Nervous System : JPNS|April 8, 2003
Pathological findings in a patient with ventilatory failure and chronic inflammatory demyelinating polyneuropathyThomas E Kimber, Richard W Orrell, Rosalind H M King, et al.
The Medical Journal of Australia|February 4, 2010
Current concepts in the management of Parkinson diseaseMichael W Hayes, Victor S Fung, Thomas E Kimber, et al.
World Journal of Gastroenterology|May 31, 2016
Gastric emptying, postprandial blood pressure, glycaemia and splanchnic flow in Parkinson's diseaseLaurence G Trahair, Thomas E Kimber, Katerina Flabouris, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 30, 2008
The distinctive movement disorder of ovarian teratoma-associated encephalitisTimothy J Kleinig, Philip D Thompson, Walid Matar, et al.
NPJ Parkinson'S Disease|July 9, 2025
Faecal microbiota transplant in Parkinson's disease: pilot study to establish safety & tolerabilityMichele De Sciscio, Robert V Bryant, Sarah Haylock-Jacobs, et al.
The Lancet. Neurology|November 19, 2022
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trialMichael J Soileau, Jason Aldred, Kumar Budur, et al.
The Lancet. Neurology|February 26, 2008
Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trialStephen M Davis, Geoffrey A Donnan, Mark W Parsons, et al.
Pageof 3